Resmed Inc. Stock
Resmed Inc. Stock
Resmed Inc. gained 0.260% compared to yesterday.
Resmed Inc. is currently one of the favorites of our community with 16 Buy predictions and no Sell predictions.
As a result the target price of 258 € shows a positive potential of 31.16% compared to the current price of 196.7 € for Resmed Inc..
Pros and Cons of Resmed Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Resmed Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Resmed Inc. | 0.260% | 1.496% | 12.851% | -20.235% | -5.659% | 19.976% | -15.688% |
| Veeva Systems A | 3.960% | 15.842% | 26.699% | -8.215% | 14.360% | 23.485% | -19.751% |
| Boston Scientific | 3.320% | 4.899% | 14.339% | -48.796% | -44.896% | -3.807% | 19.359% |
| Waters Corp. | 0.060% | 3.401% | 9.457% | 41.483% | 9.457% | 35.909% | 4.302% |
Comments
ResMed (RMD) had its "buy" rating reaffirmed by UBS Group AG.
Show more
Ratings data for RMD provided by MarketBeat
ResMed (RMD) was given a new $276.00 price target by Royal Bank Of Canada. They now have an "outperform" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat
ResMed (RMD) was given a new $266.00 price target by KeyCorp. They now have an "overweight" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat